期刊文献+

重视肺部机遇性真菌感染的影像诊断 被引量:3

原文传递
导出
摘要 近30年来,由于社会老龄化,广谱抗生素、抗肿瘤药、免疫抑制剂和介入治疗的广泛应用,器官移植的大量开展,获得性免疫缺陷综合征(AIDS)的流行,全球范围的免疫抑制人群逐年扩大,机遇性感染急剧增加。虽然真菌并非最常见的机遇性感染病原体,但其所占比例近年呈明显上升趋势。肺作为最易感脏器,占所有内脏真菌感染的60%,其他包括中枢神经系统、造血系统、消化系统、泌尿系统及骨骼软组织等部位。肺部机遇性真菌感染临床诊断困难,病死率高,已成为重要的公共卫生安全问题,对其正确认识、早期诊断和及时治疗显得越来越迫切。
作者 刘士远 薛峰
出处 《中华放射学杂志》 CAS CSCD 北大核心 2009年第1期6-7,共2页 Chinese Journal of Radiology
基金 基金项目:全军“十一五”攻关项目资助(06MB225)
  • 相关文献

二级参考文献7

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2Stevens DA,Kan VL,Judson MA,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America.Clin Infect Dis,2000,30:696-709.
  • 3Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14.
  • 4Denning DW,Kibbler CC,Barnes RA,et al.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.Lancet Infect Dis,2003,3:230-240.
  • 5Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis.Clin Infect Dis,2004,38:161-189.
  • 6Slavin MA,Szer J,Grigg AP,et al.Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.Intern Med J,2004,34:192-200.
  • 7Saag MS,Graybill RJ,Larsen RA,et al.Practice guidelines for the management of cryptococcal disease.Infectious Diseases Society of America.Clin Infect Dis,2000,30:710-718.

共引文献1704

同被引文献21

  • 1易祥华,孔洁,朱美芳,张韵,陈晓峰,钟慈声.原发性肺隐球菌病的病理诊断和超微结构观察[J].中华病理学杂志,2004,33(5):424-428. 被引量:54
  • 2应可净,江立斌,胡红杰,陈恩国,洪武军.非人类免疫缺陷病毒感染者肺隐球菌病14例影像学分析[J].中华放射学杂志,2006,40(1):104-105. 被引量:20
  • 3Legendre C,Pascual M.Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection:late-onset disease and indirect consequences.Clin Infect Dis,2008,46:732-740.
  • 4Fishman JA.Infection in solid-organ transplant recipients.N Engl J Med,2007,357:2601-2614.
  • 5Villacian JS,Paya CV.Prevention of infections in solid organ transplant recipients.Transpl Infect Dis,1999,1:50-64.
  • 6Vehreschild JJ,Ruping MJ,Steinbach A,et al.Dlagnnsis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Expert Opin Pharmacother,2010,11:95-113.
  • 7Blair JE.Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species.Curr Opin Infect Dis,2008,21:415-420.
  • 8Gabardi S,Kubiak DW,Chandraker AK,et al.Invasive fungal infections and antifungal therapies in solid organ transplant recipients.Transpl Int,2007,20:993-1015.
  • 9Lee BE,Pang XL,Robinson JL,et al.Chronic norovirus and adenovirns infection in a solid organ transplant recipient.Pediatr Infect Dis J,2008,27:360-362.
  • 10Rubin RH.The pathogenesis and clinical management.of cytomegalovirns infection in the organ transplant recipient:the end of the 'silo hypothesis'.Curr Opin Infect Dis,2007,20:399-467.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部